AU2002951271A0 - Repair of dna mutagenic damage - Google Patents

Repair of dna mutagenic damage

Info

Publication number
AU2002951271A0
AU2002951271A0 AU2002951271A AU2002951271A AU2002951271A0 AU 2002951271 A0 AU2002951271 A0 AU 2002951271A0 AU 2002951271 A AU2002951271 A AU 2002951271A AU 2002951271 A AU2002951271 A AU 2002951271A AU 2002951271 A0 AU2002951271 A0 AU 2002951271A0
Authority
AU
Australia
Prior art keywords
repair
mutagenic damage
dna mutagenic
dna
damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002951271A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kazia Research Pty Ltd
Original Assignee
Novogen Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Research Pty Ltd filed Critical Novogen Research Pty Ltd
Priority to AU2002951271A priority Critical patent/AU2002951271A0/en
Publication of AU2002951271A0 publication Critical patent/AU2002951271A0/en
Priority to AU2003257264A priority patent/AU2003257264B2/en
Priority to CNA038240114A priority patent/CN1688285A/zh
Priority to JP2004533066A priority patent/JP2006501252A/ja
Priority to CA002497823A priority patent/CA2497823A1/en
Priority to MXPA05002519A priority patent/MXPA05002519A/es
Priority to PCT/AU2003/001152 priority patent/WO2004022023A1/en
Priority to CZ20050136A priority patent/CZ2005136A3/cs
Priority to US10/526,830 priority patent/US20060153781A1/en
Priority to EP03793484A priority patent/EP1534232A4/en
Priority to TR2005/00749T priority patent/TR200500749T2/xx
Priority to NO20051605A priority patent/NO20051605D0/no
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU2002951271A 2002-09-06 2002-09-06 Repair of dna mutagenic damage Abandoned AU2002951271A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AU2002951271A AU2002951271A0 (en) 2002-09-06 2002-09-06 Repair of dna mutagenic damage
TR2005/00749T TR200500749T2 (tr) 2002-09-06 2003-09-05 Dna mutajenik hasarının tamiri
CA002497823A CA2497823A1 (en) 2002-09-06 2003-09-05 Repair of dna mutagenic damage
CNA038240114A CN1688285A (zh) 2002-09-06 2003-09-05 Dna诱变损伤的修复
JP2004533066A JP2006501252A (ja) 2002-09-06 2003-09-05 Ｄｎａ変異原性ダメージの修復
AU2003257264A AU2003257264B2 (en) 2002-09-06 2003-09-05 Repair of DNA mutagenic damage
MXPA05002519A MXPA05002519A (es) 2002-09-06 2003-09-05 Reparacion de dano mutagenico al dna.
PCT/AU2003/001152 WO2004022023A1 (en) 2002-09-06 2003-09-05 Repair of dna mutagenic damage
CZ20050136A CZ2005136A3 (cs) 2002-09-06 2003-09-05 Oprava mutagenního poskození DNA
US10/526,830 US20060153781A1 (en) 2002-09-06 2003-09-05 Repair of dna mutagenic damage
EP03793484A EP1534232A4 (en) 2002-09-06 2003-09-05 REPAIR OF MUTAGENIC DNA DAMAGES
NO20051605A NO20051605D0 (no) 2002-09-06 2005-03-30 Reparajon av DNA-mutagen skade

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002951271A AU2002951271A0 (en) 2002-09-06 2002-09-06 Repair of dna mutagenic damage

Publications (1)

Publication Number Publication Date
AU2002951271A0 true AU2002951271A0 (en) 2002-09-19

Family

ID=27671591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002951271A Abandoned AU2002951271A0 (en) 2002-09-06 2002-09-06 Repair of dna mutagenic damage

Country Status (11)

Country Link
US (1) US20060153781A1 (https=)
EP (1) EP1534232A4 (https=)
JP (1) JP2006501252A (https=)
CN (1) CN1688285A (https=)
AU (1) AU2002951271A0 (https=)
CA (1) CA2497823A1 (https=)
CZ (1) CZ2005136A3 (https=)
MX (1) MXPA05002519A (https=)
NO (1) NO20051605D0 (https=)
TR (1) TR200500749T2 (https=)
WO (1) WO2004022023A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104643057A (zh) 2002-07-24 2015-05-27 儿童医院医疗中心 含有对映体牛尿酚的组合物和产物及其用途
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
WO2004039327A2 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
EP1542654A4 (en) * 2002-09-23 2008-12-17 Novogen Res Pty Ltd TREATMENT OF PHOTOTATIOOD AND ACTINIC DETERIORATION OF THE SKIN
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
CA2738510A1 (en) * 2008-07-30 2010-02-04 Novogen Research Pty Ltd 6-substituted isoflavonoid compounds and uses thereof
HRP20240793T1 (hr) 2018-04-18 2024-09-13 Constellation Pharmaceuticals, Inc. Modulatori enzima koji modificiraju metil, njihovi pripravci i upotreba
EP3797108B1 (en) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
LT4003532T (lt) 2019-07-24 2024-11-11 Constellation Pharmaceuticals, Inc. 7-chlor-2- (4-(3-metoksiazetidin-1-il)cikloheksil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-okso-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioksol-5-karboksamido kristalinės formos
CN114831981A (zh) * 2021-02-02 2022-08-02 上海交通大学 一种ERβ选择性激动剂在抗肿瘤中的应用
CN117599041B (zh) * 2024-01-22 2024-05-03 中国人民解放军军事科学院军事医学研究院 去氢雌马酚及其衍生物作为新型辐射防护剂和细胞保护剂的医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
DE10121375B4 (de) * 2001-05-02 2014-01-16 Beiersdorf Ag Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut
DE10122342A1 (de) * 2001-05-09 2002-11-14 Beiersdorf Ag Verwendung von Isoflavonen in kosmetischen oder dermatologischen Zubereitungen

Also Published As

Publication number Publication date
NO20051605L (no) 2005-03-30
NO20051605D0 (no) 2005-03-30
TR200500749T2 (tr) 2005-10-21
EP1534232A4 (en) 2008-12-24
CZ2005136A3 (cs) 2006-04-12
EP1534232A1 (en) 2005-06-01
CN1688285A (zh) 2005-10-26
JP2006501252A (ja) 2006-01-12
CA2497823A1 (en) 2004-03-18
WO2004022023A1 (en) 2004-03-18
US20060153781A1 (en) 2006-07-13
MXPA05002519A (es) 2005-06-17

Similar Documents

Publication Publication Date Title
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003218483A1 (en) Novel expressed genes
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
AU2003236991A1 (en) Representations of processes
WO2004023359A8 (en) Defined contribution benefits tool
AU2003258005A1 (en) Deadblow hammer
AU2002951271A0 (en) Repair of dna mutagenic damage
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003244080A1 (en) Phosphodiesterase inhibitor
AU2002343940A1 (en) Anticorrosive
AU2002368194A1 (en) Tool
AU2003234045A1 (en) Anti-corrosion pigments
AU2003208693A1 (en) Manipulator
AU2003248953A1 (en) Waveform lineariser
AU2003298683A1 (en) Cable-testing adapter
AU2002349821A1 (en) Boat-anchoring equipment
AU2003301489A1 (en) Hands-fee adaptor
AU2003294705A1 (en) NtSM GENE
AU2003267384A1 (en) Bhyd gene
AU2003303132A1 (en) Hexlock wrench
AU2003263296A1 (en) Dna repair enzymes
AU2003303192A1 (en) Adapter
AU2003295573A1 (en) Modular lance
AU2003280609A1 (en) Alpha-GLUCOSIDASE INHIBITOR
AU2003217164A1 (en) Isoaspartyl repair